NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/01/2026
Back to search
Official data from USPTO
UPM PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
57
Latest update
07/21/2026
Trademark type
Combined
Nice classes
40, 42
Filing date
11/26/2002
Registration date
06/27/2006
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/01/2026
Last transaction
07/21/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/11/2002
First use in commerce
10/11/2002
Drawing code
3
Owner type
03
Owner location
BRISTOL, TN, US
Examiner
WAHLBERG, STACY B
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a distinctive stylized wording with a star-burst design to the upper left of the wording.
Holders and representatives
Holders
GREGORY PHARMACEUTICAL HOLDINGS, INC.
UPM Pharmaceuticals, Inc.
UPM Pharmaceuticals, Inc.
Representatives
Randel S. Springer Womble Bond Dickinson (US) LLP
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Manufacture of drugs for therapeutic use in humans to the order and specification of others; manufacture of clinical suppliesnamely placebos and drugsfor therapeutic use in humans to the order and specification of others
Class 42
Development services for pharmaceutical drugs for therapeutic use in humansnamely drug formulation and pre-formulationformulation development; design of drug manufacturing equipment and processes; drug and excipient analysis and testing; drug analysis and trial services
Publications
History of USPTO decisions and trademark events.
57 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
07/01/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/01/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/01/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
04/29/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/27/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/06/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/06/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/30/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/18/2016
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/18/2016
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/18/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/18/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
03/07/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/08/2016
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/27/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/28/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/28/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/27/2012
E815
TEAS SECTION 8 & 15 RECEIVED
06/20/2012
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/19/2010
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/19/2010
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
04/21/2010
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
04/21/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
06/27/2006
PUBO
PUBLISHED FOR OPPOSITION
04/04/2006
NPUB
NOTICE OF PUBLICATION
03/15/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/15/2006
ALIE
ASSIGNED TO LIE
02/09/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/30/2006
IUAA
USE AMENDMENT ACCEPTED
01/30/2006
ACEC
AMENDMENT FROM APPLICANT ENTERED
01/06/2006
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/21/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/08/2005
PAPER RECEIVED
12/08/2005
GNRT
NON-FINAL ACTION E-MAILED
06/07/2005
CNRT
NON-FINAL ACTION WRITTEN
06/07/2005
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/19/2004
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/25/2004
CNSL
LETTER OF SUSPENSION MAILED
05/19/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/12/2004
PAPER RECEIVED
03/12/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/09/2004
PAPER RECEIVED
02/09/2004
CNRT
NON-FINAL ACTION MAILED
09/11/2003
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
08/14/2003
CFIT
CASE FILE IN TICRS
08/01/2003
IUAF
USE AMENDMENT FILED
07/14/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/14/2003
PAPER RECEIVED
07/14/2003
CNRT
NON-FINAL ACTION MAILED
04/18/2003
DOCK
ASSIGNED TO EXAMINER
04/11/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/27/2003
PAPER RECEIVED
01/27/2003
Continuous trademark protection
Get notified about every new filing that threatens UPM PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.